Krystal Biotech GAAP EPS of $1.79 beats by $0.16, revenue of $119.22M misses by $1.82M (KRYS:NASDAQ)
· seekingalpha.com
Krystal Biotech (KRYS) Q2 results: GAAP EPS beats, revenue up 24% Y/Y but misses; VYJUVEK sales and FY2026 expense guidance.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...